Figure 3From: Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryIHC results for patient # 11805 (Case report 2). Results of further IHC performed for patient #11805 following the 64 microRNA assay results: A Chromogranin X100, B Synaptophysin X100Back to article page